Autoliv Increases Dividend and Share Repurchase Program

By Tamara Parker • Thursday, November 14 10:27 • Permanent Link

Autoliv, Inc. has made several significant announcements in its latest press release. The company has increased its quarterly dividend by 3% to 70 cents per share for the fourth quarter of 2024 from the previous 68 cents. This equates to an annualized total dividend of approximately $220 million.

Additionally, Autoliv has extended its current share repurchase program until the end of 2025, with up to 7.5 million shares or up to $550 million authorized for potential repurchase from the current quarter through 2025. Since 2021, the company has returned over $1.6 billion to shareholders through dividends and share repurchases, with approximately $950 million used for the repurchase of 9.5 million shares, representing 11% of the outstanding shares at the program's inception.

Furthermore, Autoliv will cancel two million treasury shares in December 2024, and the retirement of these shares, along with the retirement of shares repurchased in the quarter, will result in a decrease in the issued shares of common stock.

The company also announced its plans to host a capital markets day on June 3rd, 2025, where it will provide more details to investors, analysts, media, and other stakeholders.

Jan Carlson, the Chairman of the Board of Directors, expressed the company's commitment to creating competitive shareholder value and its dedication to returning value to its shareholders through these initiatives. He noted that this is the fourth consecutive annual 3% increase in the dividend since it was reinstated in Q2 2021.

Autoliv, Inc. (NYSE: ALV and SSE: ALIVSDB) is the worldwide leader in automotive safety systems, with a focus on developing, manufacturing, and marketing protective systems such as airbags, seatbelts, and steering wheels for major automotive manufacturers globally. In 2023, the company's products saved 35,000 lives and reduced over 450,000 injuries.

Autoliv's sales in 2023 amounted to US $10.5 billion, and it has 70,000 associates in 25 countries, with a vision of saving more lives through innovation, research, and development at its 14 technical centers and 20 test tracks.

The market has reacted to these announcements by moving the company's shares -0.7% to a price of $100.55. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.